The present invention is directed to a physical and chemical stable pharmaceutical formulation in form of aqueous suspension comprising a reconstituted pulmonary surfactant. Said formulation is suitable for the prophylaxis and/or treatment of respiratory distress syndrome (RDS) and other respiratory disorders.